Cargando…
Rehabilitation and pharmacotherapy of neuromyelitis optica spectrum disorder: A case report
BACKGROUND: Neuromyelitis optica spectrum disorder (NMOSD) is a demyelinating autoimmune disease that affects the central nervous system. It typically manifests as optic neuritis or extensive longitudinal myelitis, with or without the presence of anti-aquaporin protein 4 autoantibodies (immunoglobul...
Autores principales: | Wang, Xiao-Ju, Xia, Peng, Yang, Ting, Cheng, Kai, Chen, An-Liang, Li, Xue-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180214/ https://www.ncbi.nlm.nih.gov/pubmed/34141752 http://dx.doi.org/10.12998/wjcc.v9.i16.3951 |
Ejemplares similares
-
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014) -
Neuromyelitis Optica Spectrum Disorder: A Case Report
por: Yaregal, Samson, et al.
Publicado: (2021) -
Tozinameran: Neuromyelitis optica spectrum disorder: case report
Publicado: (2022) -
Neuromyelitis Optica Spectrum Disorder
por: Cazzaniga, Juliana, et al.
Publicado: (2023) -
Three cases of neuromyelitis optica spectrum disorder
por: Matsusue, Eiji, et al.
Publicado: (2016)